We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Study Shows Sandoz Biosimilar Equivalent to Originator Drug

News   Jul 12, 2016

 
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
 
 
 

RELATED ARTICLES

1 in 4 Statisticians Asked to Commit Scientific Fraud

News

A stunning report concludes that researchers often ask statisticians to make "inappropriate requests." Not accidental requests for incorrect statistical analyses; but unscrupulous data manipulation or even fraud.

READ MORE

Seeking Biomarkers that Predict Immunotherapy Success

News

The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG extend their collaboration to investigate the immuno-competence of urothelial cancer patients receiving immunotherapy.

READ MORE

Gene Therapy Trial a Success in Treating Rare Form of Blindness

News

Results are out from the world’s first gene therapy trial for a genetic cause of blindness, known as choroideremia.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE